Aurobindo scrip in demand despite poor show, moves up by 28% in three and half months
    September 20, 2010
    Sanjay Pingle, Mumbai

Divi's Labs plans new facility in its SEZ at a cost of Rs.200 cr
    August 07, 2010
    Sanjay Pingle, Mumbai

Lupin building up R&D capabilities for sustained growth
    August 31, 2009
    Sanjay Pingle, Mumbai

Wockhardt: High interest costs, poor export prospects may impact profitability, stock price
    December 22, 2008
    Sanjay Pingle, Mumbai

Cadila Healthcare: Tough challenges ahead to reach targets
    July 14, 2008
    Our Bureau, Mumbai

sanofi-aventis net earnings down by 2.6% in Q1
    May 03, 2007
    Our Bureau, Mumbai

Biocon: Short term outlook not bright as statin market turns tough in Europe
    August 14, 2006
    Sanjay Pingle, Mumbai

Torrent Pharma on significant growth track
    May 17, 2006
    Sanjay Pingle, Mumbai

Shasun Chemicals: Gearing to tap future opportunities
    February 16, 2006
    Sanjay Pingle, Mumbai

Wockhardt : Better days ahead
    July 06, 2005
    Sanjay Pingle, Mumbai